Trials / Completed
CompletedNCT06665230
A Clinical Study of MK-6552 and Modafinil in Healthy Men (MK-6552-005)
A Three-Period Study to Evaluate the Effects of Modafinil on the Single-Dose Pharmacokinetics of MK-6552 in Healthy Male Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to learn what happens to MK-6552 in a person's body over time. Researchers will compare what happens to levels of MK-6552 in people's blood when it is taken with and without modafinil. Researchers also want to learn about the safety of MK-6552 taken with and without modafinil and if people tolerate it.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK-6552 | Oral administration |
| DRUG | Modafinil | Oral administration |
Timeline
- Start date
- 2023-09-20
- Primary completion
- 2023-11-20
- Completion
- 2023-11-20
- First posted
- 2024-10-30
- Last updated
- 2024-10-30
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06665230. Inclusion in this directory is not an endorsement.